SCHEMBL9508500

SCHEMBL9508500

O=CC(=Cc1ncco1)c1ccc(F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
NQO2 P16083 2/20 0.34
LTA4H P09960 1/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31
TUBA3E Q6PEY2 1/20 0.31
TUBA1A Q71U36 1/20 0.31
TUBA1C Q9BQE3 1/20 0.31
TUBB6 Q9BUF5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9508496 1.00 KMT2A (0.37) KMT2ANQO2LTA4HMAOAMAOB
SCHEMBL9507418 0.74 KMT2A (0.49) KMT2ANQO2LTA4HCES2CES1
SCHEMBL9507425 0.74 KMT2A (0.49) KMT2ANQO2LTA4HCES2CES1
SCHEMBL9507278 0.72 LTA4H (0.36) KMT2ANQO2LTA4HMAOAMAOB
SCHEMBL9508489 0.72 MAOA (0.55) KMT2AMAOAMAOBRAB9AALDH1A1
SCHEMBL9507282 0.72 LTA4H (0.36) KMT2ANQO2LTA4HMAOAMAOB
SCHEMBL9508485 0.72 MAOA (0.55) KMT2AMAOAMAOBRAB9AALDH1A1
SCHEMBL31540744 0.72
SCHEMBL9507320 0.71 LTA4H (0.50) KMT2ANQO2LTA4HRAB9AALDH1A1
SCHEMBL9507327 0.71 LTA4H (0.50) KMT2ANQO2LTA4HRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0298380-B1 PROCESS FOR THE PREPARATION OF ALPHA-BETA-SUBSTITUTED ACROLEINS BASF Aktiengesellschaft (DE) 1993-09-29 EP disclosed
US-4920232-A CHEMICAL INTERMEDIATES BASF AKTIENGESELLSCHAFT (DE) 1990-04-24 US disclosed
EP-0298380-A2 Process for the preparation of alpha-beta-substituted acroleins BASF Aktiengesellschaft (DE) 1989-01-11 EP disclosed